Asthma and Obesity Diet Versus Exercise
Obesity and Asthma: Determinants of Inflammation and Effect of Intervention
1 other identifier
interventional
110
1 country
1
Brief Summary
Obesity is recognized as a pro-inflammatory condition associated with multiple chronic diseases, including asthma. The specific mechanisms linking asthma and obesity remain hypothetical. Our primary hypothesis is that inflammatory SNPs may regulate the degree of the inflammatory response, with obesity modifying the severity of the disease. In this instance, asthma that develops in the context of obesity demonstrates the potential deleterious relationship between a specific proinflammatory state (obesity) and the genetic regulators of inflammation (SNPs). Our secondary hypothesis proposes that short-term (12-weeks) weight loss by diet alone, but not exercise alone, will reduce lung specific inflammation and diminish the pro-inflammatory responses in female African American obese adolescents with asthma compared to a waiting list control group who after their initial 12 weeks then receive a combined 12-week diet plus exercise program (waiting list control/combined). A third exploratory hypothesis proposes that the frequency of identified SNPs will be significantly related to the amount of fat loss through diet, exercise or combined program and will further be mediated by specific airway and, pro-and-anti-inflammatory markers.These hypotheses will be tested using the following Specific Aims:
- 1.To determine the frequency of single nucleotide polymorphisms and SNP haplotypes in pro- and anti-inflammatory genes in female African American obese and non-obese asthmatic and non-asthmatic adolescents, 13-19 years or age.
- 2.To examine the effects of diet or exercise on lung specific inflammation (exhaled nitric oxide, \[eNO\]) and pro-and-anti-inflammatory responses in female African-American obese asthmatic and non-asthmatic adolescents compared to a waiting list control/ combined group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 19, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 4, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 4, 2016
CompletedFirst Submitted
Initial submission to the registry
June 25, 2018
CompletedFirst Posted
Study publicly available on registry
August 23, 2018
CompletedAugust 23, 2018
August 1, 2018
6.2 years
June 25, 2018
August 21, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
exhaled nitric oxide, [eNO] change
Exhaled nitric-oxide (eNO; to be performed at baseline visit and post intervention at 13 to 15 weeks): The eNO level will be measured by chemiluminescence gas analyzer (Niox®), standardized according to the American Thoracic Society guidelines, 1999 \[29\]. NO is produced in healthy airway for normal physiologic functions (maintaining airway patency). It is formed during airway inflammation and may contribute to oxidative stress. It is overproduced in the lungs of asthmatic patient. Evidence suggests that eNO may be used as marker for lung inflammation \[30-33; 112\].
Baseline visit and and post intervention at 13 to 15 weeks
Secondary Outcomes (10)
Body Mass Index Change
Baseline visit and and post intervention at 13 to 15 weeks
Single nucleotide polymorphisms (SNPs)
Baseline clinical visit
Arginase activity
Baseline clinical visit
myeloid-derived suppressor cells (MDSC)
Baseline clinical visit
Serum inflammatory markers change
Baseline visit and and post intervention at 13 to 15 weeks
- +5 more secondary outcomes
Study Arms (4)
Diet and Nutrition Education
EXPERIMENTALLifestyle counseling plus nutrition education and counseling and protein sparing modified fast diet plus supplementation of vitamins and minerals, followed by a balanced, hypo-caloric diet and nutrition education provided by a registered dietician
Exercise Instruction
ACTIVE COMPARATORLifestyle counseling plus moderate intensity, progressive exercise prescription including cardio-pulmonary, strength and flexibility exercise tailored to the individual needs of each participant.
Combined Diet and Exercise
ACTIVE COMPARATORLifestyle counseling plus dietary intervention including nutrition education and counseling and a protein sparing modified fast diet and nutrition education combined with the exercise intervention including a moderate intensity, progressive exercise prescription including cardio-pulmonary, strength and flexibility exercise tailored to the individual needs of each participant.
Control
NO INTERVENTIONDelayed intervention (waiting list) group receives no intervention for 12 weeks followed by the Diet plus Exercise intervention.
Interventions
Inter-disciplinary, interactive, family based behavioral intervention for overweight children
Eligibility Criteria
You may qualify if:
- African American Females with an age of 13-19 years will be recruited. Our aim is to target high school age youth who are most likely to exhibit autonomy and authority to control both their nutrition and exercise regimens. In addition this age range is representative of the age group most likely to access school based health centers for recruitment purposes. Lastly, the study includes the collection of blood samples for the purpose of examining varied physiologic parameters that are affected by maturation. Participants above the age of 13 are most likely pubertal and thus, less likely to be affected by maturation issues.
You may not qualify if:
- Presence of other chronic pulmonary or systemic disease.
- Presence of moderate or severe atopic dermatitis or allergic rhinitis.
- Severe asthmatic based upon American Thoracic Society (ATS) standards and/or NIH guidelines.
- Acute lower respiratory infection in the last 2 weeks before baseline eNO evaluation.
- Pregnant are nursing mothers Study participants and parents (s) will be advised of the known risks and consequences associated with the testing and also of the reasonably known risks and consequences of not undergoing testing.
- Severe or uncontrolled asthmatics will not be allowed to participate.
- Participants with a recent (in the last 2 weeks) lower respiratory infection will not be allowed to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Louisiana State University Health Sciences Center
New Orleans, Louisiana, 70112, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melinda S Sothern, PhD
Louisiana State University Health Sciences Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 25, 2018
First Posted
August 23, 2018
Study Start
May 19, 2010
Primary Completion
August 4, 2016
Study Completion
August 4, 2016
Last Updated
August 23, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share